ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,555,000 | -34.8% | 218,339 | -25.9% | 0.01% | -33.3% |
| Q2 2022 | $2,384,000 | -7.6% | 294,645 | +58.4% | 0.01% | +12.5% |
| Q1 2022 | $2,581,000 | -10.4% | 185,959 | +81.1% | 0.01% | 0.0% |
| Q4 2021 | $2,882,000 | -3.3% | 102,692 | +17.1% | 0.01% | -11.1% |
| Q3 2021 | $2,981,000 | +3.4% | 87,703 | +24.3% | 0.01% | 0.0% |
| Q2 2021 | $2,883,000 | +26.9% | 70,554 | +25.0% | 0.01% | +12.5% |
| Q1 2021 | $2,272,000 | -26.1% | 56,426 | +8.6% | 0.01% | -27.3% |
| Q4 2020 | $3,074,000 | +13.6% | 51,981 | -6.6% | 0.01% | 0.0% |
| Q3 2020 | $2,707,000 | -3.6% | 55,660 | -4.1% | 0.01% | -8.3% |
| Q2 2020 | $2,807,000 | – | 58,027 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |